| # | Drug | Count |
|---|---|---|
| 0 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 39 |
| 1 | RITONAVIR | 35 |
| 2 | ATAZANAVIR | 24 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 21 |
| 4 | LOPINAVIR AND RITONAVIR | 15 |
| 5 | RITONAVIR 100 MG | 13 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE | 13 |
| 7 | ZIDOVUDINE | 11 |
| 8 | FOLIC ACID | 7 |
| 9 | LEVETIRACETAM | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 1 | NELFINAVIR MESYLATE | 7 | 0.0033 |
| 2 | LAMIVUDINE AND ZIDOVUDINE | 21 | 0.0027 |
| 3 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 4 | FLURAZEPAM HYDROCHLORIDE | 1 | 0.0025 |
| 5 | ATAZANAVIR | 24 | 0.0017 |
| 6 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 7 | LOPINAVIR AND RITONAVIR | 15 | 0.0011 |
| 8 | ZIDOVUDINE | 11 | 0.0011 |
| 9 | RITONAVIR 100 MG | 13 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 48 | 0.0011 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 49 | 0.0008 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 65 | 0.0006 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 28 | 0.0006 |
| 4 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 6 | Prostaglandin E1 Analog [EPC] | 4 | 0.0002 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Nucleoside Analog Antiviral [EPC] | 6 | 0.0001 |